Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

modified interleukin-2 DF6215

A modified and recombinant form of the human endogenous cytokine interleukin-2 (IL-2), with potential immunostimulating and antineoplastic activities. Upon administration, modified IL-2 DF6215 targets and binds to IL-2 receptor (IL-2R) expressed on CD8+ T effector cells and activates IL-2R-mediated signaling. This enhances cytotoxic T lymphocytes (CTLs)-mediated cytotoxic immune responses against tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:modified IL-2 DF6215
Code name:DF 6215
DF-6215
DF6215
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search